🇮🇹 Italy Country × Condition
ovarian cancer Clinical Trials in Italy
Active clinical trials for ovarian cancer with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇮🇹 Italy
Active Trials in Italy (5)
NCT05983432 Phase 1
Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Enrollment
470 pts
Country
🇮🇹 Italy
SystImmune Inc.
View Trial → NCT06229522
Recruiting
Patients Derived Organoids as a Promising Tool to Tailor Ovarian Cancer Therapies (PANDORA).
Enrollment
150 pts
Country
🇮🇹 Italy
Centro di Riferimento Oncologico - ...
View Trial → NCT07070973
Recruiting
Proactive Hemodynamic Management During Cytoreductive Surgery and HIPEC
Enrollment
52 pts
Country
🇮🇹 Italy
Fondazione Policlinico Universitari...
View Trial → NCT07039331
Recruiting
Short-term Fasting Compared to Free Diet on Ovarian Cancer Patients
Enrollment
54 pts
Country
🇮🇹 Italy
Fondazione Policlinico Universitari...
View Trial → NCT06028724
Recruiting
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
Enrollment
782 pts
Country
🇮🇹 Italy
Centro di Riferimento Oncologico - ...
View Trial → Frequently Asked Questions
How many ovarian cancer clinical trials are active in Italy?
There are currently 5 active clinical trials for ovarian cancer with sites in Italy, of which 5 are actively recruiting patients.
How can I join a ovarian cancer clinical trial in Italy?
To join a ovarian cancer clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ovarian cancer trials in Italy?
Active ovarian cancer trials in Italy span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology